These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 31180921)

  • 1. Cirrhosis as a Comorbidity in Conditions Subject to the Hospital Readmissions Reduction Program.
    Rosenblatt R; Cohen-Mekelburg S; Shen N; Tafesh Z; Lucero C; Kumar S; Fortune B; Liu SY; Brown R; Jesudian A
    Am J Gastroenterol; 2019 Sep; 114(9):1488-1495. PubMed ID: 31180921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Hospital Penalty Status Under the Hospital Readmission Reduction Program and Readmission Rates for Target and Nontarget Conditions.
    Desai NR; Ross JS; Kwon JY; Herrin J; Dharmarajan K; Bernheim SM; Krumholz HM; Horwitz LI
    JAMA; 2016 Dec; 316(24):2647-2656. PubMed ID: 28027367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the Hospital Readmissions Reduction Program With Mortality During and After Hospitalization for Acute Myocardial Infarction, Heart Failure, and Pneumonia.
    Khera R; Dharmarajan K; Wang Y; Lin Z; Bernheim SM; Wang Y; Normand ST; Krumholz HM
    JAMA Netw Open; 2018 Sep; 1(5):e182777. PubMed ID: 30646181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Financial Incentives in Medicare's Hospital Readmissions Reduction Program and Hospital Readmission Performance.
    Hoffman GJ; Yakusheva O
    JAMA Netw Open; 2020 Apr; 3(4):e202044. PubMed ID: 32242906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of the Hospital Readmissions Reduction Program across Insurance Types in California.
    Zingmond DS; Liang LJ; Parikh P; Escarce JJ
    Health Serv Res; 2018 Dec; 53(6):4403-4415. PubMed ID: 29740816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the Hospital Readmissions Reduction Program With Mortality Among Medicare Beneficiaries Hospitalized for Heart Failure, Acute Myocardial Infarction, and Pneumonia.
    Wadhera RK; Joynt Maddox KE; Wasfy JH; Haneuse S; Shen C; Yeh RW
    JAMA; 2018 Dec; 320(24):2542-2552. PubMed ID: 30575880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative Effects of the Hospital Readmissions Reduction Program on Hospitals That Serve Poorer Patients.
    Wasfy JH; Bhambhani V; Healy EW; Choirat C; Dominici F; Wadhera RK; Shen C; Wang Y; Yeh RW
    Med Care; 2019 Dec; 57(12):968-976. PubMed ID: 31567860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Readmissions and costs among younger and older adults for targeted conditions during the enactment of the hospital readmission reduction program.
    Lu CH; Clark CM; Tober R; Allen M; Gibson W; Bednarczyk EM; Daly CJ; Jacobs DM
    BMC Health Serv Res; 2021 Apr; 21(1):386. PubMed ID: 33902569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further Evidence on the System-Wide Effects of the Hospital Readmissions Reduction Program.
    Demiralp B; He F; Koenig L
    Health Serv Res; 2018 Jun; 53(3):1478-1497. PubMed ID: 28480598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospital revisits within 30 days after discharge for medical conditions targeted by the Hospital Readmissions Reduction Program in the United States: national retrospective analysis.
    Wadhera RK; Joynt Maddox KE; Kazi DS; Shen C; Yeh RW
    BMJ; 2019 Aug; 366():l4563. PubMed ID: 31405902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Misclassification of Hospital Performance Under the Hospital Readmissions Reduction Program: Implications for Value-Based Programs.
    Shen C; Wadhera RK; Yeh RW
    JAMA Cardiol; 2021 Mar; 6(3):332-335. PubMed ID: 33052371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal Trends in Racial Differences in 30-Day Readmission and Mortality Rates After Acute Myocardial Infarction Among Medicare Beneficiaries.
    Pandey A; Keshvani N; Khera R; Lu D; Vaduganathan M; Joynt Maddox KE; Das SR; Kumbhani DJ; Goyal A; Girotra S; Chan P; Fonarow GC; Matsouaka R; Wang TY; de Lemos JA
    JAMA Cardiol; 2020 Feb; 5(2):136-145. PubMed ID: 31913411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Hospital Readmissions From the Emergency Department After Implementation of Medicare's Hospital Readmissions Reduction Program.
    Hsuan C; Carr BG; Hsia RY; Hoffman GJ
    JAMA Netw Open; 2020 May; 3(5):e203857. PubMed ID: 32356883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in 30- and 90-Day Readmission Rates for Heart Failure.
    Khan MS; Sreenivasan J; Lateef N; Abougergi MS; Greene SJ; Ahmad T; Anker SD; Fonarow GC; Butler J
    Circ Heart Fail; 2021 Apr; 14(4):e008335. PubMed ID: 33866827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicare's Hospital Readmission Reduction Program reduced fall-related health care use: An unexpected benefit?
    Hoffman GJ; Alexander NB; Ha J; Nguyen T; Min LC
    Health Serv Res; 2024 Feb; 59(1):e14246. PubMed ID: 37806664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the Hospital Readmissions Reduction Program Implementation With Readmission and Mortality Outcomes in Heart Failure.
    Gupta A; Allen LA; Bhatt DL; Cox M; DeVore AD; Heidenreich PA; Hernandez AF; Peterson ED; Matsouaka RA; Yancy CW; Fonarow GC
    JAMA Cardiol; 2018 Jan; 3(1):44-53. PubMed ID: 29128869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How Have 30-Day Readmission Penalties Affected Racial Disparities in Readmissions?: an Analysis from 2007 to 2014 in Five US States.
    Kaplan CM; Thompson MP; Waters TM
    J Gen Intern Med; 2019 Jun; 34(6):878-883. PubMed ID: 30737680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Analysis of Hospital Readmission Rates After the Implementation of Hospital Readmissions Reduction Program.
    Muchiri S; Azadeh-Fard N; Pakdil F
    J Patient Saf; 2022 Apr; 18(3):237-244. PubMed ID: 34292263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Readmissions Reduction Program: Mortality and Readmissions for Chronic Obstructive Pulmonary Disease.
    Puebla Neira DA; Hsu ES; Kuo YF; Ottenbacher KJ; Sharma G
    Am J Respir Crit Care Med; 2021 Feb; 203(4):437-446. PubMed ID: 32871097
    [No Abstract]   [Full Text] [Related]  

  • 20. Readmission Rates for Chronic Obstructive Pulmonary Disease Under the Hospital Readmissions Reduction Program: an Interrupted Time Series Analysis.
    Buhr RG; Jackson NJ; Kominski GF; Dubinett SM; Mangione CM; Ong MK
    J Gen Intern Med; 2020 Dec; 35(12):3581-3590. PubMed ID: 32556878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.